PAR-22-126 - Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 3
Active NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|
Expired NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications | NOT-EB-23-022 | NIBIB NCATS NCI NEI NHLBI NIGMS | Dec 13, 2023 | Sep 9, 2025 | R35, RM1, R21, R01, U01, R15, R13, K99/R00 |
| Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications. | NOT-EB-23-002 | NIBIB NCCIH NCI NHLBI NIA NIAID NICHD NIGMS | Apr 14, 2023 | Sep 9, 2025 | R01, R21, R35, R41/R42, R43/R44 |
| Notice of Special Interest (NOSI): Optimization of Data Storage and Utilization for the Sequence Read Archive (SRA) | NOT-GM-23-015 | NIGMS NLM ODSS | Dec 14, 2022 | Sep 9, 2025 | R41/R42, R43/R44, R01, K08, RM1, R21, K25, K99/R00, K23, F30, F32, F33, F31, R16, R35, R15 |

